Skip to main content
OpenTrials

Clinical trial condition

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Explore clinical trials studying Precursor Cell Lymphoblastic Leukemia-Lymphoma. Study availability and eligibility vary by location and protocol.

1,800 public trials 303 recruiting studies
Refine in advanced search Browse all conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma trial results

Recruiting

Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma

NCT06289673

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations
  • Rady Children's Hospital San Diego, California, United States
  • Our Lady of the Lakes Regional Medical Center Baton Rouge, Louisiana, United States
  • Novant Health Presbyterian Hemby Children's Hospital Charlotte, North Carolina, United States
  • Saint Francis Children's Hospital Tulsa, Oklahoma, United States
View Trial Details
Recruiting

A Clinical Study of MK-1045 (CN201) in People With Precursor B-cell Acute Lymphoblastic Leukemia (MK-1045-002)

NCT05579132

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • The Second Affiliated Hospital of Third Military Medical University ( Site 0008) Chongqing, Chongqing Municipality, China
  • Southern Medical University Nanfang Hospital ( Site 0004) Guangzhou, Guangdong, China
  • The Second Hospital of Hebei Medical University ( Site 0003) Shijiazhuang, Hebei, China
  • The First Hospital of Harbin ( Site 0005) Harbin, Heilongjiang, China
View Trial Details
Recruiting

Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia

NCT07109219

Conditions
B-cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt Lymphoma, DNA Virus Infections, +19 more
Locations
  • Research Site Duarte, California, United States
  • Research Site Jacksonville, Florida, United States
  • Research Site Chicago, Illinois, United States
  • Research Site Iowa City, Iowa, United States
View all 26 locations
View Trial Details
Recruiting

Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia

NCT05327894

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
Locations
  • Hospital de Pediatría S.A.M.I.C. "Juan P. Garrahan" Buenos Aires, Argentina
  • Australian and New Zealand Children's Haematology/Oncology Group Clayton, Victoria, Australia
  • North Adelaide- Womens and Childrens Hospital Adelaide, Australia
  • Monash Children's Hosptial Clayton, Australia
View all 124 locations
View Trial Details
Recruiting

CAR-T Cell Therapy for ALL

NCT07695012

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations
  • National University of Medical Sciences, Clinical Trial Unit Rawalpindi, Pakistan
View Trial Details
Recruiting

A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL

NCT05748171

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • St. Anna Kinderspital Vienna, Austria
  • Cliniques universitaires Saint-Luc Brussels, Bruxelles-capitale, Région de, Belgium
  • UZ Gent Ghent, Oost-vlaanderen, Belgium
  • UZ Leuven Leuven, Vlaams-brabant, Belgium
View all 68 locations
View Trial Details
Recruiting

EWALL-PH OBSERVARTORY 2022

NCT07684131

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Groupe hospitalier sud Amiens, France
  • CHU Angers Angers, France
  • CH de la cote basque Bayonne, France
  • CHU Bordeaux Bordeaux, France
View all 23 locations
View Trial Details

Related conditions